Home Duke University Press
QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Journal of Health Politics, Policy and Law 2008 33(2):319-324; DOI:10.1215/03616878-2007-063
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiMasi, J. A.
Right arrow Articles by Grabowski, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Commentary

Misleading Congress about Drug Development: Reply

Joseph A. DiMasi
Tufts University

Ronald W. Hansen
University of Rochester

Henry G. Grabowski
Duke University

The review essay by Donald Light about a Congressional Budget Office report on pharmaceutical research and development (R&D) (Light 2007) contains factual errors, leaves the reader uninformed about rebuttal responses to criticisms made in the review about studies of R&D costs, and draws erroneous conclusions about the nature of industry economics.






  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2008 by Duke University Press